SOLUTIONS - Intra vaginal rings and intra uterine devices

Product description

Ethylene-vinyl acetate copolymers (EVA) can be used as a drug eluting polymer matrix in intravaginal rings and intrauterine devices. Vaginal rings are well-known in the market, and can be designed to deliver drugs to the vagina either locally or systemically at steady rates over timescales of weeks to months.
EVA is used to control the release of contraceptive hormones in marketed vaginal ring products, and EVA-based contraceptive rings have a high degree of patient acceptability due to their ease of use.
EVA rings can be used as a platform for drug delivery beyond hormonal contraception, and can deliver a broad range of active pharmaceutical ingredients.  Examples include the delivery of microbicides for HIV prevention, peptides for systemic delivery, and chemotherapy agents delivered locally for cervical cancer.
Celanese provides a full regulatory support packages to customers seeking regulatory approval
Read more


More products from Celanese Services Germany GmbH

View all our products (23)

Products from other suppliers